JMN Financial’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,269
Closed -$4.81K – 230
2026
Q2
$4.81K Buy
+11,269
New +$9.04K ﹤0.01% 228

Other funds holding HRTX

JMN Financial's HRTX Position: Q3 2026 in Review

JMN Financial sold out of Heron Therapeutics (HRTX) in Q3 2026, closing a stake of 11,269 shares — an estimated $4.81K sold.

JMN Financial first reported a position in HRTX in Q2 2026 and held it in 1 quarter. The position peaked at $4.81K in Q2 2026. 159 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.

  • JMN Financial reported no remaining Heron Therapeutics position as of Q3 2026 after selling out during the quarter.
  • JMN Financial sold 11,269 Heron Therapeutics shares in Q3 2026, an estimated $4.81K.
  • JMN Financial first reported a position in Heron Therapeutics in Q2 2026 and held it in 1 quarter.
  • JMN Financial's Heron Therapeutics position peaked at $4.81K in Q2 2026.
  • 159 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.

Based on JMN Financial's 13F filing for Q3 2026, filed 10 Nov 2026.